nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels
|
Wilk, C. Matthias |
|
|
6 |
15 |
p. 4485-4489 |
artikel |
2 |
Akhmetzyanova I, Aaron T, Galbo P, et al. Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα. Blood Adv. 2021;5(18):3592-3608.
|
|
|
|
6 |
15 |
p. 4490 |
artikel |
3 |
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies
|
Lynch Jr, Donald R. |
|
|
6 |
15 |
p. 4645-4656 |
artikel |
4 |
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
|
Candeloro, Matteo |
|
|
6 |
15 |
p. 4516-4523 |
artikel |
5 |
CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
|
Wang, Chunxu |
|
|
6 |
15 |
p. 4617-4633 |
artikel |
6 |
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
|
Cordero-Sanchez, Celia |
|
|
6 |
15 |
p. 4471-4484 |
artikel |
7 |
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations
|
Drazer, Michael W. |
|
|
6 |
15 |
p. 4357-4359 |
artikel |
8 |
COVID-19 and venous thromboembolism risk in patients with sickle cell disease
|
Singh, Ashima |
|
|
6 |
15 |
p. 4408-4412 |
artikel |
9 |
Defective VWF secretion due to expression of MYH9-RD E1841K mutant in endothelial cells disrupts hemostasis
|
Cao, Yang |
|
|
6 |
15 |
p. 4537-4552 |
artikel |
10 |
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma
|
Martin, Thomas |
|
|
6 |
15 |
p. 4506-4515 |
artikel |
11 |
Editorial Board
|
|
|
|
6 |
15 |
p. i |
artikel |
12 |
Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide–coated nanoparticles
|
Lin, Adam Yuh |
|
|
6 |
15 |
p. 4581-4592 |
artikel |
13 |
Etra A, Gergoudis S, Morales G, et al. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Adv. 2022;6(12):3707-3715.
|
|
|
|
6 |
15 |
p. 4437-4438 |
artikel |
14 |
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis
|
Luan, Danny |
|
|
6 |
15 |
p. 4413-4423 |
artikel |
15 |
GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12
|
Zhao, Xuefei |
|
|
6 |
15 |
p. 4524-4536 |
artikel |
16 |
Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission
|
Jentzsch, Madlen |
|
|
6 |
15 |
p. 4570-4580 |
artikel |
17 |
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant
|
Jimenez Jimenez, Antonio |
|
|
6 |
15 |
p. 4491-4500 |
artikel |
18 |
Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice
|
Ren, Guohui |
|
|
6 |
15 |
p. 4403-4407 |
artikel |
19 |
Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
|
Nishiwaki, Satoshi |
|
|
6 |
15 |
p. 4558-4569 |
artikel |
20 |
In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
|
Wang, Hongjie |
|
|
6 |
15 |
p. 4360-4372 |
artikel |
21 |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study
|
Jang, Jun Ho |
|
|
6 |
15 |
p. 4450-4460 |
artikel |
22 |
Koh MJ, Merrill MH, Koh MJ, et al. Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas. Blood Adv. 2022;6(5):1420-1431.
|
|
|
|
6 |
15 |
p. 4436 |
artikel |
23 |
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
|
Ataga, Kenneth I. |
|
|
6 |
15 |
p. 4461-4470 |
artikel |
24 |
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
|
Kim, Haesook T. |
|
|
6 |
15 |
p. 4392-4402 |
artikel |
25 |
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
|
Wells, Philip S. |
|
|
6 |
15 |
p. 4605-4616 |
artikel |
26 |
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma
|
Cuffel, Alexis |
|
|
6 |
15 |
p. 4657-4660 |
artikel |
27 |
Refining the migration and engraftment of short-term and long-term HSCs by enhancing homing-specific adhesion mechanisms
|
Al-Amoodi, Asma S. |
|
|
6 |
15 |
p. 4373-4391 |
artikel |
28 |
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
|
Baech, Joachim |
|
|
6 |
15 |
p. 4427-4435 |
artikel |
29 |
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort
|
Scalzulli, Emilia |
|
|
6 |
15 |
p. 4424-4426 |
artikel |
30 |
Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors
|
Wu, Chenyan |
|
|
6 |
15 |
p. 4439-4449 |
artikel |
31 |
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
|
Tabanelli, Valentina |
|
|
6 |
15 |
p. 4634-4644 |
artikel |
32 |
Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
|
Tromp, Samantha A.M. |
|
|
6 |
15 |
p. 4501-4505 |
artikel |
33 |
Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians
|
Jadhao, Sudhir |
|
|
6 |
15 |
p. 4593-4604 |
artikel |
34 |
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
|
Thompson, Meghan C. |
|
|
6 |
15 |
p. 4553-4557 |
artikel |